This is really sad: "patent issues (specifically on living organisms) may complicate distribution for pharmaceutical companies wishing to have exclusive rights

This is really sad: "patent issues (specifically on living organisms) may complicate distribution for pharmaceutical companies wishing to have exclusive rights over their "invention", making it unlikely that a for-profit corporation will invest capital in the widespread application of this technology."